British doctors praise Merck’s antiviral pill which halves the risk of hospitalization for Covid patients
UK Covid patients will not yet get a 'changing' pill that halves the risk of being hospitalized or dying from the disease, it was revealed today.US drug giant Merck today announced landmark results from a trial of its antiviral molnupiravir.Hospitalization…